Skip to main content

Table 4 Pulmonary BALF Cell Counts at 1, 7 and 28 Days Following Oropharyngeal Aspiration of MWCNTs

From: Expansion of cardiac ischemia/reperfusion injury after instillation of three forms of multi-walled carbon nanotubes

Treatment

Dose

Total Cells x 10 5

Macrophages x10 5

Neutrophils x 10 5

Eosinophils x 10 5

Lymphocytes x 10 5

Epithelial Cells x 10 5

1 Day

SS

 

1.80 ± 0.15

1.49 ± 0.12

0.01 ± 0.01

0.0 ± 0.0

0.0 ± 0.0

0.29 ± 0.03

C-grade

1 μg

2.25 ± 0.25

0.76 ± 0.08

1.65 ± 0.21

0.0 ± 0.0

0.0 ± 0.0

0.09 ± 0.01

 

100 μg

4.64 ± 0.60*

1.12 ± 0.13

3.36 ± 0.71*

0.0 ± 0.0

0.0 ± 0.0

0.14 ± 0.05

COOH

1 μg

4.19 ± 0.45

1.42 ± 0.08

2.60 ± 0.38*

0.01 ± 0.01

0.0 ± 0.0

0.14 ± 0.02*

 

100 μg

5.30 ± 1.57*

1.25 ± 0.35

3.92 ± 1.38*

0.08 ± 0.04

0.0 ± 0.0

0.03 ± 0.01*

N-doped

1 μg

7.16 ± 0.24*

2.06 ± 0.35

4.75± 0.27*

0.01 ± 0.01

0.0 ± 0.0

0.27 ± 0.04

 

100 μg

6.22 ± 1.14*

1.84 ± 0.40

4.21 ± 0.75*

0.05 ± 0.02

0.0 ± 0.0

0.15 ± 0.01

7 Day

SS

 

4.44 ± 0.15

4.20 ± 0.14

0.0 ± 0.0

0.0 ± 0.0

0.03 ± 0.01

0.19 ± 0.01

C-grade

1 μg

4.78 ± 1.21

4.46 ± 1.17

0.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

0.31 ± 0.13

 

100 μg

2.80 ± 0.72

2.53 ± 0.67

0.04 ± 0.01

0.03 ± 0.01

0.0 ± 0.0

0.18 ± 0.07

COOH

1 μg

1.33 ± 0.08

1.07 ± 0.08*

0.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

0.25 ± 0.03

 

100 μg

3.15 ± 0.05

2.63 ± 0.12*

0.19 ± 0.08

0.12 ± 0.06

0.03 ± 0.01

0.16 ± 0.01

N-doped

1 μg

5.61 ± 1.67

5.04 ± 1.52

0.0 ± 0.0

0.0 ± 0.0

0.06 ± 0.04

0.49 ± 0.16

 

100 μg

4.92 ± 0.75

4.35 ± 0.86

0.03 ± 0.03

0.0 ± 0.0

0.07 ± 0.04

0.46 ± 0.09

28 Day

SS

 

1.30 ± 0.24

1.24 ± 0.20

0.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

0.06 ± 0.03

C-grade

1μg

1.04 ± 0.35

0.87 ± 0.26

0.0 ± 0.0

0.01 ± 0.01

0.0 ± 0.0

0.15 ± 0.07

 

100 μg

1.48 ± 0.29

1.37 ± 0.27

0.0 ± 0.0

0.0 ± 0.0

0.01± 0.01

0.10 ± 0.02

COOH

1μg

1.29 ± 0.07

1.15 ± 0.08

0.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

0.13± 0.02

 

100 μg

1.74 ± 0.23

1.60 ± 0.22

0.02 ± 0.01

0.0 ± 0.0

0.0 ± 0.0

0.10 ± 0.01

N-doped

1 μg

0.92 ± 0.29

0.86 ± 0.28

0.0 ± 0.0

0.0 ± 0.0

0.06 ± 0.04

0.05 ± 0.01

 

100 μg

1.27 ± 0.11

1.15 ± 0.10

0.0 ± 0.0

0.0 ± 0.0

0.07 ± 0.04

0.11 ± 0.01

  1. Bronchoalveolar lavage fluid cell counts following oropharyngeal aspiration of three forms of MWCNTs at 1μg and 100 μg or SS vehicle control (10% surfactant saline). The cell counts were performed at 1 day, 7 day and 28 day post-instillation. Data reported as mean ± SEM for n = 4. * indicates significance from SS, † indicates significance from 1 μg dose in same MWCNT form, P ≤ 0.05.